Switches of tyrosine‐kinase inhibitors in chronic phase of chronic myeloid leukemia in real life
Sign Up to like & getrecommendations! Published in 2018 at "American Journal of Hematology"
DOI: 10.1002/ajh.25217
Abstract: To the Editor: Imatinib has transformed chronic myeloid leukemia (CML) prognosis with a survival rate of almost 83% at 10 years. The second and third generations of tyrosine-kinase inhibitors (TKIs) have enlarged the therapeutic possibilities.… read more here.
Keywords: first line; group; switch group; leukemia ... See more keywords
Early and Late Switch from Ranibizumab to an Intravitreal Dexamethasone Implant in Patients with Diabetic Macular Edema in the Event of a Poor Anatomical Response
Sign Up to like & getrecommendations! Published in 2019 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-019-00865-7
Abstract: Background and Objective Patients with diabetic macular edema may not have optimal outcomes even with monthly ranibizumab intravitreal injections. A corticosteroid implant might be considered in such patients. The objective of this study was to… read more here.
Keywords: dexamethasone implant; switch group; switch; late switch ... See more keywords
Fabry disease under enzyme replacement therapy—new insights in efficacy of different dosages
Sign Up to like & getrecommendations! Published in 2018 at "Nephrology Dialysis Transplantation"
DOI: 10.1093/ndt/gfx319
Abstract: Background Fabry patients on reduced dose of agalsidase-beta or after switch to agalsidase-alfa show a decline in estimated glomerular filtration rate (eGFR) and an increase of the Mainz Severity Score Index. Methods In this prospective… read more here.
Keywords: switch agalsidase; group; agalsidase; agalsidase beta ... See more keywords
Switching from tenofovir alafenamide to tenofovir disoproxil fumarate improves lipid profile and protects from weight gain
Sign Up to like & getrecommendations! Published in 2022 at "AIDS"
DOI: 10.1097/qad.0000000000003245
Abstract: Background: Switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) increases low-density lipoprotein cholesterol (LDL-C) and body weight. Metabolic effects of the opposite TAF-to-TDF switch are unknown. Objectives: To investigate the effect of TAF-to-TDF… read more here.
Keywords: switch; switch group; tenofovir disoproxil; group ... See more keywords
Cost and clinical impact of a nonmedical DPP-4 inhibitor switch in patients with diabetes.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of managed care & specialty pharmacy"
DOI: 10.18553/jmcp.2021.27.7.846
Abstract: BACKGROUND: Nonmedical formulary switches (NMFS) routinely occur in managed health care plans and involve changing preferred medications for reasons outside of clinical considerations. The cost implications of NMFS are infrequently published and the clinical outcomes… read more here.
Keywords: health; cost clinical; switch group; irr ... See more keywords